1. Home
  2. GUG vs NAGE Comparison

GUG vs NAGE Comparison

Compare GUG & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guggenheim Active Allocation Fund of Beneficial Interest

GUG

Guggenheim Active Allocation Fund of Beneficial Interest

N/A

Current Price

$15.83

Market Cap

529.0M

Sector

Finance

ML Signal

N/A

Logo Niagen Bioscience Inc.

NAGE

Niagen Bioscience Inc.

HOLD

Current Price

$5.21

Market Cap

507.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GUG
NAGE
Founded
N/A
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
529.0M
507.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GUG
NAGE
Price
$15.83
$5.21
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$16.33
AVG Volume (30 Days)
80.0K
856.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.37
Revenue Next Year
N/A
$20.36
P/E Ratio
N/A
$21.29
Revenue Growth
N/A
N/A
52 Week Low
$13.90
$4.73
52 Week High
$16.50
$14.66

Technical Indicators

Market Signals
Indicator
GUG
NAGE
Relative Strength Index (RSI) 47.84 45.80
Support Level $15.46 $4.74
Resistance Level $16.17 $5.32
Average True Range (ATR) 0.23 0.28
MACD -0.03 0.04
Stochastic Oscillator 13.64 43.60

Price Performance

Historical Comparison
GUG
NAGE

About GUG Guggenheim Active Allocation Fund of Beneficial Interest

Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.

About NAGE Niagen Bioscience Inc.

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: